Krishna Institute of Medical Sciences EV/EBITDA Ratio

Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio

The Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Krishna Institute of Medical Sciences Ltd's valuation, profitability, and overall financial performance. Tracking the Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Krishna Institute of Medical Sciences Ltd (NSE: KIMS, BSE: 543308) is currently trading at ₹645.10, with a market capitalization of ₹258.93B. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio Current Value

The current Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio stands at 35.08.

The latest Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

• 2024: 35.08
• 2023: 27.33
• 2022: 19.52
• 2021: 20.91
• 2020: 0

The recent rise in Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.

What Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Krishna Institute of Medical Sciences Ltd.

Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Krishna Institute of Medical Sciences Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.